Bill > HB1717

This bill modifies provisions related to alternative therapies and treatments, specifically focusing on psilocybin and investigational drugs. For psilocybin, it creates exceptions to state and local laws for veterans and first responders aged 21 and older who are suffering from specific mental health conditions (posttraumatic stress disorder, major depressive disorder, substance use disorder) or require end-of-life care, provided they are enrolled in a study, inform the department of mental health, have physician documentation of their condition, use psilocybin under the supervision of a qualified facilitator, have the substance tested by a licensed laboratory, and adhere to dosage limits. The bill also allows licensed laboratories to test psilocybin for these individuals and protects those assisting in these therapeutic uses from civil or criminal penalties, except in cases of gross negligence or willful misconduct. Furthermore, it allocates $2 million for research on psilocybin's efficacy for these groups and mandates annual reports from the department of mental health on its implementation and outcomes, while ensuring the confidentiality of participant information. Regarding investigational drugs, the bill expands access for "eligible patients" who have terminal, life-threatening, or severely debilitating conditions, have exhausted other treatment options, and have a physician's recommendation, allowing manufacturers to provide these drugs without compensation or at cost, and protecting healthcare providers from liability for recommending or administering them, again with exceptions for gross negligence or willful misconduct. Finally, the bill establishes a study by the department of mental health, in collaboration with higher education institutions or contract research organizations, to investigate the efficacy of alternative therapies, including psilocybin, for veterans and first responders with specific mental health conditions or requiring end-of-life care, requiring progress and final reports to the governor and general assembly.